{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CAMRF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CAMRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAMRF\",,,,,undefined,":{"symbol":"CAMRF","market":"US","secType":"STK","nameCN":"Camurus AB","latestPrice":52.31,"timestamp":1748635200000,"preClose":52.31,"halted":0,"volume":0,"delay":15,"floatShares":34394269,"shares":58636918,"eps":0.360376,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-30 16:00:00 EDT Delay","open":52.31,"high":52.31,"low":52.31,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.360376,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748871000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":52.31,"volumeRatio":0.99601553943604},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAMRF\",,,,,undefined,":{"symbol":"CAMRF","floatShares":34394269,"roa":"11.09%","roe":"17.86%","lyrEps":0.773319,"volumeRatio":0.99601553943604,"shares":58636918,"dividePrice":0,"high":52.31,"amplitude":0,"preClose":52.31,"low":52.31,"week52Low":50.965,"pbRate":"8.38","psRate":"14.34","week52High":66.69,"institutionHeld":0,"latestPrice":52.31,"eps":0.360376,"divideRate":0,"volume":0,"delay":15,"ttmEps":0.360376,"open":52.31,"prevYearClose":50.965,"prevWeekClose":52.31,"prevMonthClose":52.31,"prevQuarterClose":59.975,"fiveDayClose":56,"twentyDayClose":59.975,"sixtyDayClose":59.975},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CAMRF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAMRF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538549506","title":"Camurus AB Annual General Meeting 2025: Key Resolutions and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2538549506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538549506?lang=en_us&edition=fundamental","pubTime":"2025-05-28 01:02","pubTimestamp":1748365361,"startTime":"0","endTime":"0","summary":"Camurus AB ( ($SE:CAMX) ) has shared an update. Camurus AB held its annual general meeting where key resolutions were passed, including the re-elec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/camurus-ab-annual-general-meeting-2025-key-resolutions-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/camurus-ab-annual-general-meeting-2025-key-resolutions-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AB","BK4135","BK4007","LU0029874061.USD","CAMRF","BK4590","LU0128526141.USD","BK4598"],"gpt_icon":0},{"id":"2530137383","title":"CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2530137383","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530137383?lang=en_us&edition=fundamental","pubTime":"2025-04-25 22:15","pubTimestamp":1745590500,"startTime":"0","endTime":"0","summary":"LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus  today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use  has adopted a positive opinion for market authorization of Oczyesa, octreotide subcutaneous depot , for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.1. \"We are pleased with the CHMP's positive recommendation for market authorization for Oczyesa octreotide monthly depot for the treatment of acromegaly\", says Fredrik Tiberg, President & CEO at Camurus. \"Oczyesa has the potential to advance the standard of care for patients living with acromegaly by enhancing octreotide plasma exposure and enabling easy and convenient once-monthly self-administration by patients using an autoinjector pen.\". Fredrik Joabsson, Chief Business Development OfficerTel. +46 70 776 17 37ir@camurus.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/chmp-recommends-approval-oczyesa-treatment-141500893.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chmp-recommends-approval-oczyesa-treatment-141500893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","CAMRF","BK4171","BK4534","PLD","CHMP","BK4007","BK4567","BK4156","BK4224","BK4087","BK4585"],"gpt_icon":0},{"id":"2511630349","title":"Camurus AB (FRA:7CA) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2511630349","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511630349?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:09","pubTimestamp":1739516988,"startTime":"0","endTime":"0","summary":"Total Revenue : SEK553 million, a growth of 48% year-over-year.Product Sales : SEK469 million, up 28% year-over-year and 11% quarter-over-quarter.Brixadi Royalty Income : SEK83 million, a 43% increase from the previous quarter.Total Revenue : SEK1,868 million, a 9% increase year-over-year.Earnings Per Share : SEK7.20, with a profit after tax of SEK429 million.Cash Position : SEK2.85 billion, improved by SEK101 million during the quarter.Gross Margin : 94%, an improvement of 267 basis points year-over-year.Total OPEX : SEK357 million, a 4% decrease year-over-year.R&D Investment : SEK684 million, 37% of total revenue.Profit Before Taxes : SEK186 million, an increase of SEK204 million from Q4 2023.Profit Before Taxes : SEK553 million, a 286% increase excluding one-time impacts.Brixadi Market Share : Approximately 25% of the long-acting segment.2025 Revenue Guidance: SEK2.7 billion to SEK3 billion, representing a growth of 45% to 61%.2025 Profit Before Tax Guidance: SEK0.9 billion to SEK1.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/camurus-ab-fra-7ca-q4-070948696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAMRF","AB","FRA"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAMRF\",params:#limit:5,,,undefined,":[{"date":"2024-05-08","symbol":"CAMRF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715155200000,"name":null,"time":"Pre-Market","dateTimestamp":1715140800000,"actualEps":null},{"date":"2022-11-10","symbol":"CAMRF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668070800000,"name":null,"time":"","dateTimestamp":1668056400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAMRF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAMRF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1744344000000}}}